Published in Nephrol Dial Transplant on January 01, 1990
Renal transplantation in patients with sarcoidosis: a French multicenter study. Clin J Am Soc Nephrol (2010) 0.97
Successful steroid-sparing treatment of renal limited sarcoidosis with mycophenolate mofetil. Pediatr Nephrol (2005) 0.93
Granulomatous interstitial nephritis. Clin Kidney J (2015) 0.91
Sarcoidosis presenting with hearing loss and granulomatous interstitial nephritis in an adolescent. Pediatr Nephrol (2006) 0.88
Diagnostic utility of kidney biopsy in patients with sarcoidosis and acute kidney injury. Int J Nephrol Renovasc Dis (2011) 0.82
Granulomatous interstitial nephritis: Our experience of 14 patients. Indian J Nephrol (2013) 0.79
Acute kidney injury caused by sarcoid granulomatous interstitial nephritis without extrarenal manifestations. CEN Case Rep (2015) 0.78
Single-centre experience of granulomatous interstitial nephritis-time for a new approach? Clin Kidney J (2017) 0.75
Sarcoidosis presenting as severe renin-dependent hypertension due to kidney vascular injury. Clin Kidney J (2014) 0.75
Ocular and renal sarcoidosis. J R Soc Med (1996) 0.75
Isolated renal relapse of sarcoidosis under low-dose glucocorticoid therapy. J Gen Intern Med (2008) 0.75
Granulomatous Interstitial Nephritis Presenting as Hypercalcemia and Nephrolithiasis. Case Rep Nephrol (2016) 0.75
Unexplained illness. J R Soc Med (1996) 0.75
Risk factors for HIV infection overlooked in routine antenatal care. J R Soc Med (1996) 0.75
Genitourinary sarcoidosis: An essential review for the practicing clinician. Indian J Urol (2017) 0.75
Mizoribine for renal sarcoidosis: effective steroid tapering and prevention of recurrence. Pediatr Nephrol (2008) 0.75
Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int (1996) 3.62
Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet (1999) 3.44
Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet (1997) 2.38
Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int (1999) 2.26
Anti-glomerular-basement-membrane disease after lithotripsy. Lancet (1990) 2.11
Acute renal failure associated with combined gentamicin and cephalothin therapy. Br Med J (1973) 2.10
Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci U S A (2008) 2.06
Pregnancy during dialysis: case report and management guidelines. Nephrol Dial Transplant (1998) 2.04
Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol (1998) 1.97
Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant (2001) 1.90
Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int (2006) 1.74
Inefficacy and toxicity of pefloxacin in focal and segmental glomerulosclerosis with steroid-resistant nephrotic syndrome. Lancet (1993) 1.72
Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet (1999) 1.68
Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis (2006) 1.67
Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol (2000) 1.66
Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int (1978) 1.56
Treatment of cystinuria. Pediatr Nephrol (1999) 1.56
Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet (1998) 1.55
Genetic heterogeneity of Alport syndrome. Kidney Int (1985) 1.55
Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol (1995) 1.48
Collagen alpha5 and alpha2(IV) chain coexpression: analysis of skin biopsies of Alport patients. Kidney Int (2007) 1.48
Renal prognosis in Alport's and related syndromes: influence of the mode of inheritance. Nephrol Dial Transplant (1989) 1.48
Gitelman syndrome comes of age. Nephrol Dial Transplant (1998) 1.47
Autosomal dominant polycystic kidney disease with primary hyperaldosteronism. Nephrol Dial Transplant (1992) 1.46
The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol (1999) 1.44
MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet (1999) 1.44
Overlap syndrome between FMF and TRAPS in a patient carrying MEFV and TNFRSF1A mutations. Clin Exp Rheumatol (2007) 1.42
[Comparative pharmacokinetics and renal accumulation of the iodized contrast media: ioxitalamic acid, ioxaglic acid and iohexol in the rabbit]. Pathol Biol (Paris) (1987) 1.42
Acute renal failure in pregnancy. Baillieres Clin Obstet Gynaecol (1994) 1.39
[Periarteritis nodosa in a dental prosthetist]. Presse Med (1994) 1.39
Sclerochoroidal calcification associated with Gitelman syndrome. Am J Ophthalmol (1999) 1.38
Urinary calculi: review of classification methods and correlations with etiology. Scanning Microsc (1993) 1.37
Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) (1995) 1.35
Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet (2001) 1.34
A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol (1999) 1.34
Pharmacokinetics of temocillin (BRL 17421) in subjects with normal and impaired renal function. J Antimicrob Chemother (1983) 1.34
Uremic and non-uremic complications in acute renal failure: Evaluation of early and frequent dialysis on prognosis. Kidney Int (1972) 1.33
The clinical spectrum of hereditary nephritis. Kidney Int (1985) 1.33
Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int (1992) 1.30
Diagnostic procedures and long-term prognosis in bilateral renal cortical necrosis. Kidney Int (1973) 1.27
Ofloxacin pharmacokinetics in renal failure. Antimicrob Agents Chemother (1987) 1.27
The renal histopathology in systemic vasculitis: an international survey study of inter- and intra-observer agreement. Nephrol Dial Transplant (1996) 1.25
Alport's syndrome: experience at Hôpital Necker. Kidney Int Suppl (1982) 1.25
Randomised controlled trial of enalapril and beta blockers in non-diabetic chronic renal failure. BMJ (1994) 1.24
Gentamicin-induced nephrotoxicity: a cell biology approach. Kidney Int (1980) 1.22
Pharmacokinetics of cefoxitin sodium in normal subjects and in uraemic patients. J Antimicrob Chemother (1978) 1.21
Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: I, Medical staff. Lancet (1981) 1.21
Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol (1992) 1.21
Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet (1993) 1.20
Liver changes and complications in adult polycystic kidney disease. Adv Nephrol Necker Hosp (1985) 1.20
Detection of hepatitis B antigen in circulating immune complexes in acute and chronic hepatitis. Scand J Immunol (1977) 1.20
Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet (1996) 1.20
Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum (1982) 1.19
Tissue distribution of dialysis amyloidosis. Clin Nephrol (1987) 1.19
Effects of blood pressure and antihypertensive treatment on progression of advanced chronic renal failure. Am J Kidney Dis (1993) 1.18
Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients. Lancet (1981) 1.18
Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol (1993) 1.17
Acute renal thrombosis induced by angiotensin-converting enzyme inhibitors in patients with renovascular hypertension. Nephron (1991) 1.17
Pregnancy in women with impaired renal function. Clin Nephrol (1997) 1.16
Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet (2000) 1.16
Senior-Loken syndrome (nephronophthisis and tapeto-retinal degeneration): a study of 8 cases from 5 families. Clin Nephrol (1976) 1.15
The pharmacokinetics of cefotaxime and its metabolites in subjects with normal and impaired renal function. Rev Infect Dis (1983) 1.15
Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults. Antimicrob Agents Chemother (1988) 1.14
Renal vascular lesions in lupus nephritis. Medicine (Baltimore) (1997) 1.14
Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet (1998) 1.13
Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes. Kidney Int (1990) 1.13
Pharmacokinetics of ceftazidime in normal and uremic subjects. Antimicrob Agents Chemother (1984) 1.13
Age and gender-related incidence of chronic renal failure in a French urban area: a prospective epidemiologic study. Nephrol Dial Transplant (1996) 1.12
Autosomal recessive polycystic kidney disease in adulthood. Nephrol Dial Transplant (2001) 1.11
Pharmacokinetics of norfloxacin in renal failure. J Antimicrob Chemother (1984) 1.10
Relationship between the integrity of Bowman's capsule and the composition of cellular crescents in human crescentic glomerulonephritis. Lab Invest (1987) 1.07
Acute renal artery thrombosis associated with factor V Leiden mutation. Nephrol Dial Transplant (1996) 1.07
Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. Kidney Int (1998) 1.07
Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis (1998) 1.07
Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome). Lab Invest (1972) 1.07
Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int (1986) 1.06
Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic Biol Med (1996) 1.06
Light drinking has positive public health consequences. Ann Oncol (2013) 1.05
Renal prognosis in women with hereditary nephritis. Clin Nephrol (1985) 1.05
Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol (1999) 1.05
Urinary stones in HIV-1-positive patients treated with indinavir. Lancet (1997) 1.04
Karyomegalic interstitial nephritis. Am J Kidney Dis (1996) 1.03
Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments. Am J Hum Genet (1992) 1.03
Anemia and secondary hyperparathyroidism. Arch Intern Med (1978) 1.02
Henoch-Schönlein nephritis in children and adults. Morphological features and clinicopathological correlations. Ann Med Interne (Paris) (1999) 1.02
Retinoic acid for treatment of multicentric Castleman's disease. Lancet (1999) 1.02
Medical treatment of cystinuria: critical reappraisal of long-term results. J Urol (2000) 1.02